Trial intelligence / Profile preview

RADAR: Raltegravir and Darunavir in treatment-naive HIV patients

NCT00677300Phase 4Completed

Sponsor
Dallas VA Medical Center
Start
Jan 2009
Primary completion
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Dallas VA Medical Center. Started Jan 2009; status: completed.

02

Drugs

raltegravir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00677300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00677300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call